# Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS

> **NCT06587698** · NA · RECRUITING · sponsor: **Peking University Third Hospital** · enrollment: 300 (estimated)

## Conditions studied

- Polycystic Ovarian Syndrome

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** BeiDouGen
- **DRUG:** Sitagliptin+BeiDouGen

## Key facts

- **NCT ID:** NCT06587698
- **Lead sponsor:** Peking University Third Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-21
- **Primary completion:** 2028-07-01
- **Final completion:** 2029-07-01
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-09-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06587698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06587698, "Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06587698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*